Prothena
PRTA
$20.56
Share price
-3.43%
Change (1 day)
-62.47%
Change (1 year)
Categories
Prothena (PRTA) - Cash on Hand
Cash on Hand as of December 2023 : $0.61 B
According to Prothena's latest financial reports the company has $0.61 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Prothena - Cash on Hand chart (from 2012 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.61 B | -12.89% |
| 2022-12-31 | $0.71 B | 22.68% |
| 2021-12-31 | $0.57 B | 96.05% |
| 2020-12-31 | $0.29 B | -21.38% |
| 2019-12-31 | $0.37 B | -12.14% |
| 2018-12-31 | $0.42 B | 2.4% |
| 2017-12-31 | $0.41 B | 7.93% |
| 2016-12-31 | $0.38 B | 4.41% |
| 2015-12-31 | $0.37 B | 26.23% |
| 2014-12-31 | $0.29 B | 66.17% |
| 2013-12-31 | $0.17 B | 41.5% |
| 2012-12-31 | $0.12 B | |
| 2011-12-31 | $N/A |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Amarin Corporation
AMRN | $0.32 B | -48.18% | 🇮🇪 Ireland |
 Alnylam Pharmaceuticals
ALNY | $2.43 B | 294.19% | 🇺🇸 USA |
 Alkermes ALKS | $0.77 B | 24.99% | 🇮🇪 Ireland |